Literature DB >> 429787

Protection from natural infection after live influenza virus immunization in an open population.

G Rocchi, L Carlizza, M Andreoni, G Ragona, C Piga, A Pelosio, A Volpi, A Muzzi.   

Abstract

Live attenuated influenza vaccine containing the recombinant of A/Victoria/3/75 with A/PR/8/34 virus was administered to healthy adults in a field trial aimed at evaluating protection provided by immunization. The study was designed to measure the effect of vaccination on absenteeism from respiratory disease during a natural influenza epidemic. A total of 2115 male employees of the public transport service of Rome volunteered to participate in the trial, 1050 and 1065 receiving vaccine and placebo respectively, in a randomized blind fashion. Vaccination procedure was completed by the end of December 1976. A small-sized outbreak of influenza, due to a viral strain antigenically homologous to the vaccine, occurred during the month of February 1977. Analysis of absenteeism data, classified according to medical certificate, indicated that morbidity from respiratory disease was reduced in vaccinees compared with controls during the epidemic month; the rate of increase of morbidity compared with that of the preceding month was then three times lower in vaccinees than in controls and the difference in absenteeism between the two groups greatly exceeded the ordinary fluctuation that was observed during non-epidemic periods.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 429787      PMCID: PMC2130141          DOI: 10.1017/s002217240002564x

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  15 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  Trials of Live Influenza Vaccine in the Royal Air Force.

Authors:  J C McDonald; A J Zuckerman; A S Beare; D A Tyrrell
Journal:  Br Med J       Date:  1962-04-14

3.  Methods for current statistical analysis of excess pneumonia-influenza deaths.

Authors:  Robert E Serfling
Journal:  Public Health Rep       Date:  1963-06       Impact factor: 2.792

4.  Field trial of live attenuated influenza A/B ("Alice"/R-75) vaccine.

Authors:  M W Rytel; L J Jackson; R A Niebojewski; J L Haagensen; M A Rosenkranz
Journal:  Am J Epidemiol       Date:  1977-01       Impact factor: 4.897

5.  Properties of A/Victoria/3/75 recombinants: development of an attenuated strain RIT 4050.

Authors:  M Lobmann; A Delem; D Jovanović
Journal:  Dev Biol Stand       Date:  1977 Jun 1-3

6.  Studies of respiratory function in volunteers given live influenza virus vaccine.

Authors:  K G Nicholson; C V Lawford; D A Tyrrell
Journal:  Dev Biol Stand       Date:  1977 Jun 1-3

7.  Oral influenza vaccination with live attenuated viruses. 1. Acceptability, immunogenicity and transmissibility.

Authors:  F L Petrilli; P Crovari; P Cuneo-Crovari; G Badolati; R Canepa
Journal:  Boll Ist Sieroter Milan       Date:  1975-10-20

8.  Immune response to vaccination with a live influenza virus (H3N2) vaccine ("Ann" strain).

Authors:  J M Prévost; J Peetermans; F Lamy; C Huygelen
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

9.  Field study with a live influenza vaccine (RIT 4050) in children.

Authors:  C Kunz; H Hofmann
Journal:  Dev Biol Stand       Date:  1977 Jun 1-3

10.  Excess mortality from influenza in a large urban population, Rome, Italy, 1956--76.

Authors:  G Ragona; G Giunchi; G Rocchi; A Muzzi; A De Felici
Journal:  J Hyg (Lond)       Date:  1978-04
View more
  2 in total

1.  Influenza vaccination with live-attenuated and inactivated virus-vaccines during an outbreak of disease.

Authors:  G Rocchi; G Ragona; C Piga; A Pelosio; A Volpi; S Vella; N Legniti; A de Felici
Journal:  J Hyg (Lond)       Date:  1979-12

Review 2.  Vaccines for preventing influenza in healthy adults.

Authors:  Vittorio Demicheli; Tom Jefferson; Eliana Ferroni; Alessandro Rivetti; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.